Search Results - "Bartlett, J. W."

Refine Results
  1. 1
  2. 2

    Exaggeration of PFS by blinded, independent, central review (BICR) by Stone, A., Gebski, V., Davidson, R., Bloomfield, R., Bartlett, J.W., Sabin, A.

    Published in Annals of oncology (01-02-2019)
    “…Recent published studies have shown meaningful discrepancies between local investigator and blinded, independent, central review (BICR) assessed median…”
    Get full text
    Journal Article
  3. 3

    Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment by Schott, J.M, Bartlett, J.W, Barnes, J, Leung, K.K, Ourselin, S, Fox, N.C

    Published in Neurobiology of aging (01-08-2010)
    “…Abstract Cerebral atrophy rate is increasingly used as an outcome measure for Alzheimer's disease (AD) trials. We used the Alzheimer's disease Neuroimaging…”
    Get full text
    Journal Article
  4. 4

    Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals by Paterson, R W, Bartlett, J W, Blennow, K, Fox, N C, Shaw, L M, Trojanowski, J Q, Zetterberg, H, Schott, J M

    Published in Translational psychiatry (29-07-2014)
    “…We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer…”
    Get full text
    Journal Article
  5. 5

    Routine Acid Decalcification of Bone Marrow Samples Can Preserve DNA for FISH and CGH Studies in Metastatic Prostate Cancer by Brown, R.S.D, Edwards, J, Bartlett, J.W, Jones, C, Dogan, A

    “…Production of paraffin-section material from tissue samples that contain bone requires decalcification. Techniques such as acidic decalcification or EDTA…”
    Get full text
    Journal Article
  6. 6

    Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis : Sample size estimates by ANDERSON, Valerie M, BARTLETT, Jonathan W, FOX, Nick C, FISNIKU, Leonora, MILLER, David H

    Published in Journal of neurology (01-11-2007)
    “…Brain atrophy, thought to reflect neuroaxonal degeneration, may be considered an objective marker of disease progression in multiple sclerosis (MS). Our…”
    Get full text
    Journal Article
  7. 7

    Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease by BARTLETT, J. W., DE STAVOLA, B. L., MEADE, T. W.

    Published in Journal of thrombosis and haemostasis (01-02-2009)
    “…Background: Although fibrinogen is known to be an independent population‐level risk factor for cardiovascular disease in healthy individuals, less is known…”
    Get full text
    Journal Article
  8. 8

    4'-Modified analogs of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase by Wolfe, Michael S, Lee, Younha, Bartlett, William J, Borcherding, David R, Borchardt, Ronald T

    Published in Journal of medicinal chemistry (01-05-1992)
    “…The carbocyclic adenosine analogues aristeromycin and neplanocin A both display significant S-adenosyl-L-homocysteine (AdoHcy) hydrolase inhibitory activity…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Technical basis for EPA's proposed regulation on the cleanup of sites contaminated with radioactivity by Wolbarst, A B, Mauro, J, Anigstein, R, Back, D, Bartlett, J W, Beres, D, Chan, D, Clark, M E, Doehnert, M, Durman, E, Hay, S, Hull, H B, Lailas, N, MacKinney, J, Ralston, L, Tsirigotis, P L

    Published in Health physics (1958) (01-11-1996)
    “…The U.S. Environmental Protection Agency is proposing a regulation for the protection of the public from radioactive contamination at sites that are to be…”
    Get more information
    Journal Article
  11. 11

    Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration by LEUNG, Kelvin K, BARTLETT, Jonathan W, BARNES, Josephine, MANNING, Emily N, OURSELIN, Sebastien, FOX, Nick C

    Published in Neurology (12-02-2013)
    “…To quantify the regional and global cerebral atrophy rates and assess acceleration rates in healthy controls, subjects with mild cognitive impairment (MCI),…”
    Get full text
    Journal Article
  12. 12

    Exaggeration of PFS by blinded, independent, central review (BICR) by Stone, A, Gebski, V, Davidson, R, Bloomfield, R, Bartlett, J W, Sabin, A

    Published in Annals of oncology (01-02-2019)
    “…Recent published studies have shown meaningful discrepancies between local investigator and blinded, independent, central review (BICR) assessed median…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival by Skillbäck, Tobias, Farahmand, Bahman, Bartlett, Jonathan W, Rosén, Christoffer, Mattsson, Niklas, Nägga, Katarina, Kilander, Lena, Religa, Dorota, Wimo, Anders, Winblad, Bengt, Rosengren, Lars, Schott, Jonathan M, Blennow, Kaj, Eriksdotter, Maria, Zetterberg, Henrik

    Published in Neurology (18-11-2014)
    “…OBJECTIVES:We hypothesized that CSF neurofilament light (NFL) levels would be elevated in dementias with subcortical involvement, including vascular dementia…”
    Get full text
    Journal Article
  16. 16

    Effect of insulin on phosphorus metabolism in red blood cells from patients with schizophrenia and psychotic depressions by Tabechian, H, Altman, K I, Young, R B, Bartlett, Jr, J W, Young, L E

    Published in Biochemical medicine and metabolic biology (01-10-1987)
    “…In an exploratory study of the metabolism of selected intermediates of glycolysis in rbc of patients with schizophrenia and with major depressive disorders,…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus by Petersen, Irene, Crozier, Alexander, Buchan, Iain, Mina, Michael J, Bartlett, Jonathan W

    Published in Clinical epidemiology (01-01-2021)
    “…Testing for SARS-CoV-2 internationally has focused on COVID-19 diagnosis among symptomatic individuals using reverse transcriptase polymerase chain reaction…”
    Get full text
    Journal Article
  20. 20